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Introduction
 
Chronological lifespan assays in yeast rely on promoting a culture’s quiescent 
stationary phase by calorie restriction. In this phase, anaerobic fermentation of sugars 
is curtailed and aerobic respiration begins as a more efficient metabolic mechanism. 
This shift in glucose utilization can be accomplished by reduced TOR pathway 
signaling, a complex regulator of cell growth and cell cycle in which various 
environmental growth condition signals are integrated to activate or inhibit the Ser/
Thr kinase activity of Tor13. Optimal growth conditions promote TOR signaling 
causing macromolecule biosynthesis, sugar fermentation with increased metabolism, 
and progression through cell cycle3. Many downstream effects of TOR signaling can be 
silenced by cell treatment with Rapamycin, which binds to Tor1 and inhibits kinase 
domain function, drastically increasing a cell population’s chronological lifespan.  
 
 Mitochondrial electron transport chain (ETC) machinery, whose activity is 
modulated by TOR signaling, is the primary site of superoxide formation. Superoxide 
is a reactive oxygen species (ROS) produced by premature electron leakage directly to 
oxygen, producing dangerous hydroxyl radicals via the Haber-Weiss reaction2. From 
here, the ROS can diffuse through the cell causing the damage to DNA, lipid 
peroxidation, and mitochondrial dysfunction associated with premature cell aging and 
death2.  
 
 A primary defense of free radical damage as a respiratory by-product is the 
neutralization of superoxide by superoxide dismutase 1 (SOD1), which requires copper 
and zinc as cofactors in the conversion of superoxide to less harmful hydrogen 
peroxide2. Copper is additionally utilized in cytochrome c oxidase as an electron 
transferring group, and is required for the continuous movement of high energy 
electrons through the ETC, thereby limiting the potential for electron leakage and 
ROS4. 
 
 A 2005 cell array study identified a set of yeast gene deletions involved in copper 
homeostasis, SOD1 among them, that conferred resistance to the expected inhibition of 
growth and proliferation characterized by rapamycin treatment1. Copper, given its 
two roles in defending against ROS production and induced cell aging, is here 
modulated by extracellular supplementation to further elucidate its functionality in 
the context of Rapamycin treatment and SOD1 deletion strains. 
Materials and Methods   
 
Yeast strains and growth conditions: 
Wild type and SOD1 deletion S. cerevisiae were both of the BY4743 strain and were cultured (32° C) in 
standard YPD liquid media overnight prior to experimental culture inoculation. Experimental cultures 
of ​𝟏/𝟓 YPD (50 mL, 1:5 media:flask volume) were inoculated (OD600 0.1) and treated with cupric 
sulfate (.5 mM) and Rapamycin (30 nM in EtOH), with appropriate control flask combinations. All 
experimental cultures aged in a shaker (250 rpm, 32° C) for the duration of the lifespan assay. 
  
Trypan blue staining: 
Chronological lifespan was assayed by assessing percent viability of yeast cell cultures over time via 
Trypan Blue staining (4% Trypan Blue diluted 1:4) to visualize dead vs. live cells. Quantification of live 
cell density utilized hemocytometer slides to count average cell number within a fixed volume (average 
of five .2x.2x.1 mm square spaces) after even cell dispersal by vortex mixing (2800 rpm, 8 seconds).  
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Results
Conclusions and Future Directions
 
Chronological lifespan analysis of Rapamycin treatment on ΔSOD1 yeast yields 
observable lifespan extension in the mutant strain, inconsistent with corresponding 
growth observations made by Xie MW et al. (Figure 5A). The normal outcome of 
lifespan extension conferred by Rapamycin, through TOR inhibition, is present in 
SOD1 mutants. This suggests the notable possibility of Rapamycin treatment giving 
both advantageous growth and lifespan extension in these mutants by reducing the 
overall production of ROS over a yeast’s metabolic lifetime. 
Copper supplementation on Rapamycin treated SOD1 mutants results in cell viability 
disadvantage over most of a chronological lifespan (Figure 5B). SOD1 mutants’ 
sensitivity to ROS can be aggravated by increased intracellular copper, leading to 
metal toxicity by copper’s participation in the Fenton reaction to produce hydroxyl 
radicals that contribute to premature cell aging. However, Figure 5C shows copper 
supplementation to be clearly advantageous to lifespan in SOD1 mutants when treated 
with Rapamycin. These data indicate a functional consequence of rapamycin 
treatment in suppressing overall metabolic activity, and therefore cytochrome C 
oxidase expression. In cells lacking Rapamycin treatment, as in Figure 5C, there could 
be a greater metabolic demand for copper to function in cytochrome C oxidase, and 
supplementation ensures that more ETC machinery is able to operate, lessening 
electron leakage and subsequent ROS production.    
To further elucidate these findings, cytochrome C oxidase expression levels within 
rapamycin treated and control SOD1 mutants can be assessed, along with trials of 
copper chelation, to determine whether a correlation exists between cytochrome C 
oxidase function and availability of copper. Additionally, ROS levels can be quantified 
at time points in Figure 5A’s CLS assay to identify whether reduction in ROS 
production contributes to lifespan extension in SOD1 mutants treated with 
Rapamycin. 
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Figure 1. Electron transport 
chain formation and 
neutralization of superoxide. 
Figure 2. Haber-Weiss 
reaction of superoxide to 
produce hydroxyl radical by 
iron or copper  metal catalysis. 
Figure 3. Trypan Blue 
stained yeast in 
hemocytometer microscopy 
cell viability assay. 
Figure 4. Experimental cultures in temperature 
controlled shaker. A) 
C) 
B) 
(Turrens JF. 2003)2 
Figure 5. Chronological lifespan assays of experimental yeast cultures. A) lifespan of two 
SOD1 deletion strain yeast cultures with no copper supplementation, and one with 30 nM 
Rapamycin treatment. B) Lifespan of two SOD1 deletion strain yeast treated with 30 nM 
Rapamycin, and one with .5 mM copper supplementation. C) Lifespan of two SOD1 
deletion strain yeast without Rapamycin treatment, and one with .5 mM copper 
supplementation. 
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